The association between plasma homocysteine levels, methylation capacity and incident osteoporotic fractures.

[1]  A. Uitterlinden,et al.  Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence , 2011, BMC geriatrics.

[2]  T. Siebel,et al.  High bone concentrations of homocysteine are associated with altered bone morphology in humans. , 2011, The British journal of nutrition.

[3]  R. Jonge,et al.  Pneumocystis pneumonia and measurement of S-adenosylmethionine plasma levels , 2011 .

[4]  M. Blauth,et al.  Outcome in geriatric fracture patients and how it can be improved , 2010, Osteoporosis International.

[5]  U. Ozekıcı,et al.  Erratum to: Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women , 2010, Archives of Gynecology and Obstetrics.

[6]  H. Blom,et al.  Inhibition of methylation decreases osteoblast differentiation via a non-DNA-dependent methylation mechanism. , 2010, Bone.

[7]  J. V. van Meurs,et al.  Body mass index is an important determinant of methylation biomarkers in women of reproductive ages. , 2009, The Journal of nutrition.

[8]  A. LaCroix,et al.  Homocysteine levels and risk of hip fracture in postmenopausal women. , 2009, The Journal of clinical endocrinology and metabolism.

[9]  Britt Wildemann,et al.  Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. , 2009, Bone.

[10]  J. Eisman,et al.  Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. , 2009, JAMA.

[11]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[12]  J. Beilby,et al.  The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women , 2009, Osteoporosis International.

[13]  Satoshi Inoue,et al.  The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures , 2008, Journal of Bone and Mineral Metabolism.

[14]  L. Bouter,et al.  Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study. , 2008, Clinical science.

[15]  B. Bagni,et al.  Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. , 2008, Bone.

[16]  J. Riancho,et al.  MTHFR C677T Polymorphism and Osteoporotic Fractures , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[17]  S. Vollset,et al.  Plasma Homocysteine, Folate, and Vitamin B12 and the Risk of Hip Fracture: The Hordaland Homocysteine Study , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  W. Herrmann,et al.  The role of hyperhomocysteinemia as well as folate, vitamin B6 and B12 deficiencies in osteoporosis – a systematic review , 2007, Clinical chemistry and laboratory medicine.

[19]  J. Riancho,et al.  MTHFR Polymorphism and Bone Mineral Density: Meta-Analysis of Published Studies , 2006, Calcified Tissue International.

[20]  S. Vollset,et al.  Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. , 2006, Archives of internal medicine.

[21]  A. Favier,et al.  A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice , 2006, Clinical chemistry and laboratory medicine.

[22]  H. Blom,et al.  Stable-isotope dilution liquid chromatography-electrospray injection tandem mass spectrometry method for fast, selective measurement of S-adenosylmethionine and S-adenosylhomocysteine in plasma. , 2005, Clinical chemistry.

[23]  B. Langdahl,et al.  Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD , 2005, Osteoporosis International.

[24]  O. Johnell,et al.  Requirements for DXA for the management of osteoporosis in Europe , 2005, Osteoporosis International.

[25]  A. Hofman,et al.  Homocysteine levels and the risk of osteoporotic fracture. , 2004, The New England journal of medicine.

[26]  D. Kiel,et al.  Homocysteine as a predictive factor for hip fracture in older persons. , 2004, The New England journal of medicine.

[27]  B. Abrahamsen,et al.  Association of a Common Allelic Polymorphism (C677T) in the Methylene Tetrahydrofolate Reductase Gene with a Reduced Risk of Osteoporotic Fractures. A Case Control Study in Danish Postmenopausal Women , 2002, Calcified Tissue International.

[28]  I. Pogribny,et al.  Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. , 2001, The Journal of nutrition.

[29]  W. Haefeli,et al.  Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease. , 2001, Atherosclerosis.

[30]  I. Pogribny,et al.  Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA Hypomethylation* , 2000, The Journal of Biological Chemistry.

[31]  H. Blom,et al.  Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. , 1996, Biochimica et biophysica acta.

[32]  Harry K. Genant,et al.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. , 1993, The American journal of medicine.

[33]  G. Cantoni,et al.  The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine. , 1959, The Journal of biological chemistry.